Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576020 | Increasing the stability of agents for the treatment of keratinous material | 🖼🧊📄§ | 2026-03-17 | 2040-02-05 | 0 | 31 |
| 12576021 | Method of making and using a skin moisturizing formulation | 🖼🧊📄§ | 2026-03-17 | 2041-06-18 | 0 | 31 |
| 12576019 | Personal cleansing composition with an organic acid having a pKa greater than 2.7 | 🖼🧊📄§ | 2026-03-17 | 2042-10-28 | 0 | 31 |
| 12576018 | Active agents for skin and hair care with sensory modifying properties | 🖼🧊📄§ | 2026-03-17 | 2039-02-04 | 0 | 31 |
| 12576026 | Formulations of nebivolol | 🖼🧊📄§ | 2026-03-17 | 2041-07-08 | 0 | 31 |
| 12576028 | Pharmaceutical or nutraceutical self-emulsifying solid dispersion composition | 🖼🧊📄§ | 2026-03-17 | 2043-01-18 | 0 | 31 |
| 12576029 | Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells | 🖼🧊📄§ | 2026-03-17 | 2043-07-12 | 0 | 31 |
| 12576025 | Pharmaceutical parenteral composition of dual GLP1/2 agonist | 🖼🧊📄§ | 2026-03-17 | 2040-06-12 | 0 | 31 |
| 12576027 | Diclofenac topical formulation with a high absorption rate | 🖼🧊📄§ | 2026-03-17 | 2042-06-22 | 0 | 31 |
| 12576034 | Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione | 🖼🧊📄§ | 2026-03-17 | 2040-05-14 | 0 | 31 |
| 12576035 | Polymeric implants with high drug loading and long-acting drug release and methods of making the same | 🖼🧊📄§ | 2026-03-17 | 2040-01-31 | 0 | 31 |
| 12576032 | Liquid clonidine extended release composition | 🖼🧊📄§ | 2026-03-17 | 2044-01-23 | 0 | 31 |
| 12576039 | Lipid-polymer compositions and methods of use | 🖼🧊📄§ | 2026-03-17 | 2041-05-18 | 0 | 31 |
| 12576038 | Composition, lipid particle manufacturing kit, substance delivery method, and detection method | 🖼🧊📄§ | 2026-03-17 | 2041-09-10 | 0 | 31 |
| 12576044 | Treatment of Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2043-05-03 | 0 | 31 |
| 12576046 | Aqueous paediatric retinol formulations | 🖼🧊📄§ | 2026-03-17 | 2039-11-26 | 0 | 31 |
| 12576048 | Anti-cancer activity of adamantane derivatives | 🖼🧊📄§ | 2026-03-17 | 2039-12-05 | 0 | 31 |
| 12576047 | Telomerase activating compounds for use in fertility and related applications | 🖼🧊📄§ | 2026-03-17 | 2043-08-25 | 0 | 31 |
| 12576050 | Dosage regime | 🖼🧊📄§ | 2026-03-17 | 2039-10-17 | 0 | 31 |
| 12576051 | Methods and composition for treating respiratory obstructive diseases | 🖼🧊📄§ | 2026-03-17 | 2040-07-30 | 0 | 31 |
| 12576049 | Onychomycosis treatment methods | 🖼🧊📄§ | 2026-03-17 | 2042-04-04 | 0 | 31 |
| 12576055 | Disease detection and treatment based on trimethyl-lysine levels | 🖼🧊📄§ | 2026-03-17 | 2039-02-01 | 0 | 31 |
| 12576054 | Vigabatrin liquid pharmaceutical composition | 🖼🧊📄§ | 2026-03-17 | 2043-05-16 | 0 | 31 |
| 12576056 | Amino acid-containing granules | 🖼🧊📄§ | 2026-03-17 | 2040-09-18 | 0 | 31 |
| 12576059 | Methods and compositions for treatment of inflammatory disease | 🖼🧊📄§ | 2026-03-17 | 2044-03-21 | 0 | 31 |
| 12576061 | Agent for inducing regression of triglyceride deposit atherosclerosis | 🖼🧊📄§ | 2026-03-17 | 2041-03-05 | 0 | 31 |
| 12576060 | Water soluble 3-O-acetyl-11-keto-β-boswellic acid and metal ion compositions, process for their preparation and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2041-06-23 | 0 | 31 |
| 12576063 | Implantable drug delivery devices for localized drug delivery | 🖼🧊📄§ | 2026-03-17 | 2040-12-18 | 0 | 31 |
| 12576066 | Methods and compositions for treatment of mydriasis | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576065 | Enhancing autophagy or increasing longevity by administration of urolithins | 🖼🧊📄§ | 2026-03-17 | 2045-04-04 | 0 | 31 |
| 12576064 | Urolithin gummy (pectin) formulations | 🖼🧊📄§ | 2026-03-17 | 2045-08-27 | 0 | 31 |
| 12576075 | Combination therapies for treating cancer | 🖼🧊📄§ | 2026-03-17 | 2039-10-30 | 0 | 31 |
| 12576071 | Pharmaceutical compositions | 🖼🧊📄§ | 2026-03-17 | 2044-12-02 | 0 | 31 |
| 12576072 | Liquid pharmaceutical composition | 🖼🧊📄§ | 2026-03-17 | 2041-12-03 | 0 | 31 |
| 12575549 | Application of TPK as a target in Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2042-02-02 | 0 | 31 |
| 12577209 | Amino acid compositions | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576041 | Transient expression of biologic materials | 🖼🧊📄§ | 2026-03-17 | 2042-07-14 | 0 | 31 |
| 12576070 | Medicine for improving state of pregnancy, and use thereof | 🖼🧊📄§ | 2026-03-17 | 2042-11-23 | 0 | 31 |
| 12576100 | Nucleic acid agents modulating SLAMF6 isoforms | 🖼🧊📄§ | 2026-03-17 | 2040-06-23 | 0 | 31 |
| 12570757 | Antibodies against the poliovirus receptor (PVR) and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-10-07 | 0 | 31 |
| 12569422 | Composition and method of inhibiting cortisone reductase by applying it to the skin | 🖼🧊📄§ | 2026-03-10 | 2039-10-10 | 0 | 31 |
| 12571800 | Means and methods for treating angiogenesis-related diseases | 🖼🧊📄§ | 2026-03-10 | 2042-10-14 | 0 | 31 |
| 12570966 | Mutated PIGGYBAC® transposase | 🖼🧊📄§ | 2026-03-10 | 2039-12-09 | 0 | 31 |
| 12570735 | Compositions and methods for treating inflammasome related diseases or conditions | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12570605 | Indole compounds, and preparation methods, and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-09-02 | 0 | 31 |
| 12570606 | Myeloperoxidase imaging agents | 🖼🧊📄§ | 2026-03-10 | 2042-04-29 | 0 | 31 |
| 12570687 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | 🖼🧊📄§ | 2026-03-10 | 2040-09-14 | 0 | 31 |
| 12570689 | Purification of GLP-1 analogues | 🖼🧊📄§ | 2026-03-10 | 2040-02-05 | 0 | 31 |
| 12570694 | Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12570708 | Recombinant proteins and their therapeutic uses | 🖼🧊📄§ | 2026-03-10 | 2044-07-02 | 0 | 31 |